Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Tumours × toripalimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Nasopharyngeal Carcinoma 33 Carcinoma, Non-Small-Cell Lung 22 Carcinoma, Hepatocellular 19 Esophageal Squamous Cell Carcinoma 18 Triple Negative Breast Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 17 Breast Neoplasms 14 Melanoma 13 Advanced Solid Tumor 13 Stomach Neoplasms 12 Uterine Cervical Neoplasms 10 Small Cell Lung Carcinoma 10 Neoplasms 10 Colorectal Neoplasms 10 Recurrence 8 Carcinoma, Transitional Cell 8 Solid Tumor 6 Sarcoma 6 Head and Neck Neoplasms 6 Carcinoma, Renal Cell 6 Neoplasm Metastasis 5 Liver Neoplasms 5 Esophageal Neoplasms 5 Rectal Neoplasms 4 Pancreatic Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Ovarian Neoplasms 3 Lymphoma 3 Locally Advanced Rectal Cancer 3

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04737122 2023-10-10

Study of LM-061 in Subjects in Advanced Tumors

LaNova Medicines Limited

Phase 1 Terminated

Advanced Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡